Filter Results:
(324)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
Show Results For
- All HBS Web (324)
- Faculty Publications (138)
- 23 Mar 2003
- Research & Ideas
AIDS in Africa—What’s the Solution?
5th Annual Africa Business Conference at Harvard Business School on March 8. Much of the debate over AIDS in Africa has surrounded the high cost of the drugs that have turned the deadly disease into one that patients in the West can now... View Details
Keywords: by Julie Jette
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 01 Dec 2013
- News
To Market, to Market
Inhibitors of proteins that play an important role in cholesterol and fat metabolism, to be developed as potential therapeutics for the treatment of diseases such as metabolic syndrome, type 2 diabetes, coronary artery disease, and some... View Details
- 01 Jun 2012
- News
The Power of Philanthropy
announced its approval of Kalydeco, a drug produced by Vertex that will immediately help some 1,200 cystic fibrosis patients and is viewed as a breakthrough precursor drug to forthcoming products that will... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details
- 06 Dec 2021
- News
Vision: Sound Science
of scientific inquiry in gene-based hearing loss and inner-ear drug delivery: “In some infants with profound hearing impairment, there’s a mutation in one of those genes that results in loss of a protein that inner-ear cells need to... View Details
Keywords: Deb Blagg
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical company that manufactures and sells... View Details
- 24 Jan 2025
- News
The Network Effect
Karan Mathur (left) and Dina Model (Illustration by Gisela Goppel) When Dina Model and Karan Mathur (both MBA 2015) met through mutual friends during their first year at HBS, neither was envisioning a future business deal. “We didn’t realize that we had shared... View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes Dan Morrell: In 2008, Jim Langford (MBA 1984) became the executive director of the Georgia Meth Project, a nonprofit that blanketed his native state with a graphic, disturbing ad campaign dedicated to... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- 10 Oct 2017
- First Look
First Look at New Research and Ideas, October 10, 2017
watch a series of real, crime-related videos (while the control group watches non-crime-related videos). Not previously victimized participants exposed to the treatment video show significant changes in cortisol level, heart rate, and... View Details
Keywords: Sean Silverthorne
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details
- Web
Finalists | New Venture Competition
2024) Daniel Erdosy We help drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. SaveSpace Katharina Kelm (MBA 2024) Kelvin Kassis... View Details
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of... View Details
Keywords: by Julia Hanna
- 27 Feb 2024
- Blog Post
Fighting Cancer with a Novel Cell Therapy: Ananya Zutshi (MS/MBA '21)
and will call myself an engineer forever. But I recognized that my strengths and experiences are well suited for the business side of drug development.” Guardian Bio’s cell therapy uses dendritic cells, an essential component in the human... View Details
- 05 May 2020
- News
“Walking a Tightrope”
is going to be transmitted yet again to the next generation. A year and a half, two years ago now, we ran into Drew. He was in a drug treatment program called Provoking Hope based in McMinnville, Oregon.... View Details
- 03 Jul 2012
- Research & Ideas
HBS Faculty on Supreme Court Health Care Ruling
invasive surgery, radiation, and chemotherapy for cancer, for example) with drugs that can palliate and perhaps cure genetically-linked diseases. But like most new technologies, these are hugely expensive to develop, and initially, to... View Details
- 01 Mar 2006
- News
Using IT to Heal U.S. Health Care
health information network are expected to be substantial. A RAND Corporation study estimates savings to the U.S. health-care system of up to $162 billion a year by improving medical-care delivery, reducing medical errors and adverse drug... View Details